Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New drug gilteritinib takes on standard therapy in FLT3 leukemia trial
Disease control CompletedThis Phase 2 trial tests whether the oral drug gilteritinib works better than midostaurin for adults with a specific genetic subtype of acute myeloid leukemia (FLT3-mutated AML). All 181 participants also receive standard chemotherapy. The goal is to see which drug leads to more …
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug duo aims to tackle tough lymphoma
Disease control CompletedThis study tested whether adding ixazomib to the standard drug ibrutinib can help people with mantle cell lymphoma that has returned or not responded to prior treatment. Forty-three adults received both pills by mouth in cycles. Researchers looked for the best dose and measured h…
Phase: PHASE1, PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy plus chemo shows promise in tough lung cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. The trial included 214 adults whose cancer could not be removed by surgery. Participants received either the combination or a s…
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC